Nexstem recently secured $3.5 million in funding, according to reporting from Inc42. The round was led by investors InfoEdge, Gruhas, Zupee and Smile Group.
Deeptech innovator Nexstem operates with a focus on neuroscience. The company develops brain-computer interface devices that are non-invasive and equipped with software for decoding brain signals. Nexstem’s goal is to make its brain-computer interface technology accessible for researchers, clinicians and developers to address real-world challenges.
Nexstem’s technology is capable of restoring lost motor functions and augmenting a person’s cognitive capabilities, the same article mentioned. Backed by its fresh capital, the company plans to expand its product ecosystem and portfolio of intellectual property. Nexstem will also invest in advancing the deployment its biosignal infrastructure.
